Santhera Pharmaceuticals Holding AG (SANN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.199x

Based on the latest financial reports, Santhera Pharmaceuticals Holding AG (SANN) has a cash flow conversion efficiency ratio of 1.199x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-14.16 Million ≈ $-17.91 Million USD) by net assets (CHF-11.82 Million ≈ $-14.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Santhera Pharmaceuticals Holding AG (SANN) total market value for the company's overall valuation and market capitalisation.

Santhera Pharmaceuticals Holding AG - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Santhera Pharmaceuticals Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Santhera Pharmaceuticals Holding AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Santhera Pharmaceuticals Holding AG ranked by their cash flow conversion efficiency. Explore how high is Santhera Pharmaceuticals Holding AG's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Chen Full International Co Ltd TWO:8383	-0.006x
Stille AB ST:STIL	0.015x
Monogram Orthopaedics Inc. Common Stock NASDAQ:MGRM	-0.267x
E. W. Scripps Co Class A NASDAQ:SSP	0.135x
Jena Acquisition Corporation II NYSE:JENA	-0.001x
Amazing Microelectronic TWO:6411	0.027x
Cohen & Steers Real Estate Opportunities and Income Fund NYSE:RLTY	N/A
BROOGE ENERGY DL-0001 F:3SF	N/A

Annual Cash Flow Conversion Efficiency for Santhera Pharmaceuticals Holding AG (2006–2025)

The table below shows the annual cash flow conversion efficiency of Santhera Pharmaceuticals Holding AG from 2006 to 2025. View SANN share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF-11.82 Million ≈ $-14.94 Million	CHF-34.76 Million ≈ $-43.95 Million	2.942x	+329.37%
2024-12-31	CHF27.70 Million ≈ $35.02 Million	CHF-35.53 Million ≈ $-44.92 Million	-1.283x	-262.65%
2023-12-31	CHF59.94 Million ≈ $75.78 Million	CHF47.27 Million ≈ $59.76 Million	0.789x	+15.44%
2022-12-31	CHF-43.69 Million ≈ $-55.23 Million	CHF-29.84 Million ≈ $-37.73 Million	0.683x	+102.43%
2021-12-31	CHF1.33 Million ≈ $1.68 Million	CHF-37.36 Million ≈ $-47.23 Million	-28.132x	-510.82%
2020-12-31	CHF-6.35 Million ≈ $-8.03 Million	CHF-43.51 Million ≈ $-55.01 Million	6.848x	+5506.63%
2019-12-31	CHF21.25 Million ≈ $26.86 Million	CHF2.60 Million ≈ $3.28 Million	0.122x	+108.98%
2018-12-31	CHF27.83 Million ≈ $35.18 Million	CHF-37.87 Million ≈ $-47.87 Million	-1.361x	-10.74%
2017-12-31	CHF32.26 Million ≈ $40.78 Million	CHF-39.63 Million ≈ $-50.11 Million	-1.229x	-236.64%
2016-12-31	CHF74.35 Million ≈ $94.00 Million	CHF-27.14 Million ≈ $-34.31 Million	-0.365x	-73.20%
2015-12-31	CHF106.25 Million ≈ $134.32 Million	CHF-22.39 Million ≈ $-28.31 Million	-0.211x	+40.08%
2014-12-31	CHF17.24 Million ≈ $21.79 Million	CHF-6.06 Million ≈ $-7.67 Million	-0.352x	+64.17%
2013-12-31	CHF7.11 Million ≈ $8.98 Million	CHF-6.98 Million ≈ $-8.82 Million	-0.982x	-4.32%
2012-12-31	CHF11.73 Million ≈ $14.83 Million	CHF-11.04 Million ≈ $-13.96 Million	-0.941x	-103.34%
2011-12-31	CHF42.98 Million ≈ $54.34 Million	CHF-19.89 Million ≈ $-25.15 Million	-0.463x	-385.61%
2010-12-31	CHF69.63 Million ≈ $88.03 Million	CHF-6.64 Million ≈ $-8.39 Million	-0.095x	+61.65%
2009-12-31	CHF83.51 Million ≈ $105.58 Million	CHF-20.75 Million ≈ $-26.24 Million	-0.249x	+43.18%
2008-12-31	CHF104.47 Million ≈ $132.08 Million	CHF-45.69 Million ≈ $-57.77 Million	-0.437x	-164.92%
2007-12-31	CHF135.51 Million ≈ $171.33 Million	CHF-22.37 Million ≈ $-28.28 Million	-0.165x	-1.08%
2006-12-31	CHF152.05 Million ≈ $192.23 Million	CHF-24.83 Million ≈ $-31.40 Million	-0.163x	--

About Santhera Pharmaceuticals Holding AG

SW:SANN Switzerland Biotechnology

Market Cap

$286.57 Million

CHF226.67 Million CHF

Market Cap Rank

#15866 Global

#170 in Switzerland

Share Price

CHF15.94

Change (1 day)

+1.27%

52-Week Range

CHF9.58 - CHF18.54

All Time High

CHF1070.00